Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

ALDX, CRC, NIHD, TDOC Stock Update

Published 09/28/2018, 07:26 AM
Updated 07/09/2023, 06:31 AM

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), one of our swing trades, I thought had a very good day on Thursday after the pop and pullback. It had a positive inside day, up 1.00, or 7 1/2%, to 14.35, on 4.5 million shares and may work its way higher. I’m still looking for high teens, low 20’s.

California Resources Corporation (NYSE:CRC) had a nice pop of 1.86, or 4%, to 47.73, on 1.55 million shares on Thursday after it pulled back for a couple days. Once this gets through 48.85, it’s on its way to the low to mid 50’s. I like the look of it. Let’s see if it will extend in the next couple days to get to at least 53-54.

NII Holdings, Inc. (NASDAQ:NIHD)) may be coming out. On Thursday it popped 41 cents, or 8.76%, to 5.96, on 1.4 million shares. It looks like it’s breaking out of its pattern. It formed a breakaway gap, a platform, and three moving averages. Watch this one going forward. From 6 1/4, we should see 7 1/4, possibly 9.00.

Teladoc, Inc. (NYSE:TDOC)) has a long-term, beautiful move, and is currently in a rising channel. On Thursday it was up 3.95, or 5%, to 82.50, on 1.7 million shares. At the top of that channel in a juxtaposition, the long-term trendline comes in around 95.00. That’s the next target.

Stocks on the long side included Applied Genetic Technologies Corporation (AGTC), Aldeyra Therapeutics, Inc. (ALDX), Amarin Corporation plc (AMRN), Accuray Incorporated (ARAY), Aurinia Pharmaceuticals Inc. (AUPH), Cool Holdings, Inc. (AWSM), California Resources Corporation (CRC), iShares MSCI Brazil ETF USD Acc (CSBR), EyePoint Pharmaceuticals, Inc. (EYPT), GW Pharmaceuticals plc (GWPH), HTG Molecular Diagnostics, Inc. (HTGM), Intelsat S.A. (I), India Globalization Capital, Inc. (IGC), NII Holdings, Inc. (NIHD), Pacific Biosciences of California, Inc. (PACB), ProQR Therapeutics N.V. (PRQR), Protagonist Therapeutics, Inc. (PTGX), Ra Pharmaceuticals, Inc. (RARX), Square, Inc. (NYSE:SQ), Teladoc, Inc. (TDOC), and Vanda Pharmaceuticals Inc. (VNDA).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here.

Latest comments

Thank you as always !
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.